The application of the autologous serum eye drops results in significant improvement of the conjunctival status in patients with the dry eye syndrome;Aplikace autologního séra-očních kapek vede ke statisticky významnému zlepšení stavu spojivky pacientů se syndromem suchého oka-pilotní studie

Ceska a Slovenska Oftalmologie

Volumn 64, Issue 2, 2008, Pages 52-56

  Jirsová, Kateřina ^a   Hrdlickova E ^a   Alfakih, A ^a   Juklova K ^a   Filipec, M ^a,b   Faltus, V ^c   Vesela V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Evropská O ní Klinika Lexum   (Czech Republic)

^c INSTITUTE OF ANALYTICAL CHEMISTRY   (Czech Republic)

Author keywords

Autologous serum eye drops; Conjunctiva; Dry eye syndrome

Indexed keywords

EID: 41649099693     PISSN: 12119059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Brignole, F., De Saint-Jean, M., Goldschild, M. et al.: Expression of Fas-Fas ligand antigens and apoptotic marker APO2.7 by the human conjunctival epithelium. Positive correlation with class II HLA DR expression in inflammatory ocular surface disorders. Exp Eye Res., 67, 1998, 6: 687-697.
2. Brignole, F., Pisella, P.J., Goldschild, M., et al.: Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci., 41, 2000, 6: 1356-1363.
3. del Castillo, J.M., de la Casa, J.M., Sardina, R.C. et al.: Treatment of recurrent corneal erosions using autologous serum. Cornea, 21, 2002, 8: 781-783.
4. Djalilian, A.R., Mahesh, S.P., Koch, C.A. et al.: Survival of donor epithelial cells after limbal stem cell transplantation. Invest Ophthalmol Vis Sci., 46, 2005, 3: 803-807.
5. Esquenazi, S., He, J., Bazan, H.E. et al.: Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea, 24, 2005, 8: 992-997.
6. Fox, R.I., Chan, R., Michelson, J.B. et al.: Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum., 27, 1984, 4: 459-461.
7. Gavrieli, Y., Sherman, Y. Ben-Sasson, S.A.: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol., 119, 1992, 3: 493-500.
8. Geerling, G., Maclennan, S. Hartwig, D.: Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol., 88, 2004, 11: 1467-1474.
9. Gobbels, M. Spitznas, M.: Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Ophthalmology, 99, 1992, 6: 873-878.
10. Goto, E., Shimmura, S., Shimazaki, J. et al.: Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea, 20, 2001, 8: 807-810.
11. Hori, Y., Spurr-Michaud, S., Russo, C.L. et al.: Differential regulation of membrane-associated mucins in the human ocular surface epithelium. Invest Ophthalmol Vis Sci., 45, 2004, 1: 114-122.
12. Jirsova, K., Juklova, K., Vesela, V. et al.: Morphological and immunocytochemical characterization of snake-like chromatin cells. Histol Histopathol., 21, 2006, 4: 355-360.
13. Kojima, T., Ishida, R., Dogru, M. et al.: The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol., 139, 2005, 2: 242-246.
14. Matsumoto, Y., Dogru, M., Goto, E. et al.: Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111, 2004, 6: 1115-1120.
15. Matsuo, H., Tomidokoro, A., Tomita, G. et al.: Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb. Eye 19, 2005, 1: 23-28.
16. McDonnell, P.J., Schanzlin, D.J.Rao, N.A.: Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol 106, 1988, 10: 1423-1425.
17. Mishima, H., Nakamura, M., Murakami, J. et al.: Transforming growth factor-beta modulates effects of epidermal growth factor on corneal epithelial cells. Curr Eye Res 11, 1992, 7: 691-696.
18. Nelson, J.D.: Diagnosis of keratoconjunctivitis sicca. Int Ophthalmol Clin 34, 1994, 1: 37-56.
19. Nelson, J.D.Farris, R.L.: Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca. Arch Ophthalmol 106, 1988, 4: 484-487.
20. Nelson, J.D., Havener, V.R.Cameron, J.D.: Cellulose acetate impressions of the ocular surface. Dry eye states. Arch Ophthalmol 101, 1983, 12: 1869-1872.
21. . Nishida, T., Ohashi, Y., Awata, T. et al.: Fibronectin. A new therapy for corneal trophic ulcer. Arch Ophthalmol 101, 1983, 7: 1046-1048.
22. Noble, B.A., Loh, R.S., MacLennan, S. et al.: Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol., 88, 2004, 5: 647-652.
23. Ogawa, Y., Okamoto, S., Mori, T. et al.: Autologous serum eye drops for the treatment of severe dry eye in patients with chronic grafl-versus-host disease. Bone Marrow Transplant., 31, 2003, 7: 579-583.
24. Ohashi, Y., Motokura, M., Kinoshita, Y. et al.: Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci., 30, 1989, 8: 1879-1882.
25. Perry, H.D. Donnenfeld, E.D.: Dry eye diagnosis and management in 2004. Curr Opin Ophthalmol., 15, 2004, 4: 299-304.
26. Pflugfelder, S.C., Solomon, A. Stern, M.E.: The diagnosis and management of dry eye: a twenty-five-year review. Cornea, 19,2000, 5: 644-649.
27. Poon, A.C., Geerling, G., Dart, J.K. et al.: Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol., 85, 2001, 10: 1188-1197.
28. Rivas, L., Oroza, M.A., Perez-Esteban, A. et al.: Morphological changes in ocular surface in dry eyes and other disorders by impression cytology. Graefes Arch Clin Exp Ophthalmol 230, 1992, 4: 329-334.
29. Shimmura, S., Ueno, R., Matsumoto, Y. et al.: Albumin as a tear supplement in the treatment of severe dry eye. Br J Ophthalmol., 87,2003, 10: 1279-1283.
30. Tananuvat, N., Daniell, M., Sullivan, L.J. et al.: Controlled study of the use of autologous serum in dry eye patients. Cornea, 20, 2001, 8: 802-806.
31. . Tseng, S.C.: Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology, 92, 1985, 6: 728-733.
32. Tseng, S.C.: Topical tretinoin treatment for dry-eye disorders. Int Ophthalmol Clin., 27, 1987, 1: 47-53.
33. Tseng, S.C., Maumenee, A.E., Stark, W.J., et al.: Topical retinoid treatment for various dry-eye disorders. Ophthalmology, 92, 1985, 6: 717-727.
34. Tsubota, K., Goto, E., Fujita, H., et al.: Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol., 83, 1999, 4: 390-395.
35. Tsubota, K., Goto, E., Shimmura, S., et al.: Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology, 106, 1999, 10: 1984-1989.
36. van Setten, G.B., Viinikka, L., Tervo, T., et al.: Epidermal growth factor is a constant component of normal human tear fluid. Graefes Arch Clin Exp Ophthalmol., 227, 1989, 2: 184-187.
37. Young, A.L., Cheng, A.C., Ng, H.K., et al.: The use of autologous serum tears in persistent corneal epithelial defects. Eye, 18, 2004, 6: 609-614.